For xenographic pharmacogenomics, the Novartis patient-derived xenograft encyclopedia (PDXE) data object expressed a strong correlation between trastuzumab response and ERBB2 expression from breast cancer patient-derived xenograft models (Supplementary Fig. 4)19. Here, ERBB2 is linked to breast carcinoma.